News

Pralatrexate is a specialized antifolate chemotherapy drug primarily used for the treatment of relapsed or refractory peripheral T-cell lymphoma (PTCL). Since its introduction, it has become an important therapeutic option for patients who have limited treatment alternatives.

MAAA-1162a (Deruxtecan, MC-GGFG-DXd) is a drug-linker complex of detrastuzumab (DS-8201a), formed by DXd (MAAA-1181a, payload) and maleimide-tetrapeptide linker (MC-GGFG) through chemical coupling.

The synthesis of doxercalciferol (1α-hydroxyvitamin D₂) usually starts with vitamin D₂ (ergocalciferol) as the starting material, and introduces the 1α-hydroxyl group through selective protection, oxidation, and photoisomerization

This article examines why your reference standard for Sucrose Octasulfate-Aluminum Complex (Orforglipron Impurity 18) must meet the highest standards of purity, characterization, and regulatory compliance, and explores how Cosper Pharma Tech Co., Ltd. can support your impurity profiling and ANDA filing journey.

​Migalastat is an innovative oral therapy designed for the treatment of Fabry disease, a rare genetic lysosomal storage disorder that affects multiple organs and significantly reduces quality of life. Unlike traditional enzyme replacement therapies, Migalastat works by stabilizing certain forms of the body’s own enzyme, allowing it to function more effectively.